Incidence and predictors of axillary metastasis in T1 carcinoma of the breast

Journal of the American College of Surgeons

Volumn 183, Issue 3, 1996, Pages 185-189

  Giuliano, Armando E ^a   Barth, Andreas M ^b   Spivack, Brian ^a   Beitsch, Peter D ^a   Evans, Sheila W ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INCIDENCE; CANCER STAGING; FEMALE; FROZEN SECTION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0029758383     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Carter, C. L., Allen, C., and Henson, D. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer, 1989, 63: 181-187.
2. Rosen, P. P., and Groshen, S. Factors influencing survival and prognosis in early breast carcinoma. Surg. Clin. North Am., 1990, 70: 937-960.
3. Holmberg, L., Lindgren, A., Norden, T., and others. Age as a determinant of axillary node involvement in invasive breast cancer. Acta Oncol., 1992, 31: 533-538.
4. Ranaboldo, C. J., Mitchel, A., Royle, G. T., and others. Axillary nodal status in women with screen-detected breast cancer. Eur. J. Surg. Oncol., 1993, 19: 130-133.
5. Chadha, M., Chabon, A. B., Friedmann, P., and Vikram, B. Predictors of axillary lymph node metastases in patients with T1 breast cancer. Cancer, 1994, 73: 350-353.
6. Silverstein, M. J., Gierson, E. D., Waisman, J. R., and others. Axillary lymph node dissection for T1a breast carcinoma: is it indicated? Cancer, 1994, 73: 664-667.
7. Cady, B. The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer, 1994, 73: 505-508.
8. Giuliano, A. E., Kirgan, D. M., Guenther, J. M., and Morton, D. L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg., 1994, 220: 391-401.
9. Morton, D., Wen, D.-R., Wong, J., and others. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg., 1992, 127: 392-399.
10. Harris, J. R., Lippman, M. E., Veronesi, U., and Willett, W. Breast cancer. N. Engl. J. Med., 1992, 327: 473-480.
11. Mansour, E. G., Ravdin, P. M., and Dressier, L. Prognostic factors in early breast carcinoma. Cancer, 1994, 74: 381-400.
12. Wold, L. E., Ingle, J. M., Pisansky, T. M., and others. Prognostic factors for patients with carcinoma of the breast. Mayo Clin. Proc., 1995, 70: 678-679.
13. Weldner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med., 1991, 324: 1-8.
14. Fisher, B., Redmond, C., Fisher, E. R., and others. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N. Engl. J. Med., 1985, 312: 674-678.
15. Harris, J. R., and Osteen, R. T. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res. Treat., 1985, 5: 17-21.
16. Hellman, S. Natural history of small breast cancers. J. Clin. Oncol., 1994, 12: 2229-2234.
17. Rosen, P. P., Groshen, S., Saigo, P. E., and others. A long-term follow-up study of survival in Stage I (T1N0M0) and Stage II (T1N1M0) breast carcinoma. J. Clin. Oncol., 1989, 7: 355-366.
18. NIH Consensus Development Conference. Treatment of early stage breast cancer. J. Natl. Cancer Inst., 1992, 11: 1-5.
19. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet, 1992, 339: 1-15.
20. Henderson, I. C. Adjuvant systemic therapy for early breast cancer. Cancer, 1994, Suppl., 74: 401-409.
21. Moffat, F. L., Senofsky, G. M., Davis, K., and others. Axillary node dissection for early breast cancer: some is good but all is better. J. Surg. Oncol., 1992, 51: 8-13.
22. Ludwig Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet, 1990, 335: 1565-1568.
23. Trojani, M., de Mascarel, I., Bonichon, F., and others. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br. J. Cancer, 1987, 55: 303-306.
24. Wells, C. A., Heryet, A., Brochier, J., and others. The immunocytochemical detection of axillary micrometastases in breast cancer, Br. J. Cancer, 1984, 50: 193-197.
25. Hainsworth, P. J., Tjandra, J. J., Stillwell, R. G., and others. Detection and significance of occult metastases in node-negative breast cancer. Br. J. Surg., 1993, 80: 459-463.
26. de Mascarel, I., Bonichon, F., Coindre, J. M., and Trojani, M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br. J. Cancer, 1992, 66: 523-527.
27. Noguchi, S., Aihara, T., Nadamori, S., and others. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer, 1994, 74: 1595-1600.
28. Huvos, A. G., Hutter, R. V. P., and Berg, J. W. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann. Surg., 1971, 173: 44-46.